CapMan - Company Announcement

CapMan to exit OneMed

CapMan Plc Stock exchange release 10 December 2010 9.45 a.m. EET


CapMan to exit OneMed

The funds managed by CapMan and the other owners of OneMed Group Oy will sell
their shareholding in OneMed Group Oy to 3i and OneMed's management. CapMan
funds' ownership in OneMed was approx. 66% prior to the transaction. The impact
of the transaction on CapMan Plc Group's cash flow is expected to be approx. EUR
13 million in 2011. The transaction also moves Finnmezzanine III B and CapMan
Buyout VIII funds considerably closer to carry. The closing of the transaction
is subject to the approval of competition authorities and it is expected to be
finalised in February 2011. The exit from OneMed does not have substantial
impact on CapMan Plc Group's result in 2010 or 2011.

In connection with the closing of the transaction, approximately one fourth of
the CapMan Buyout VIII fund's paid-in capital will be returned to investors in
the fund. CapMan is a substantial investor in CapMan Buyout VIII fund, and as a
consequence of this fund investment the impact of the transaction on CapMan Plc
Group's cash flow is expected to be approx. EUR 13 million in 2011.

OneMed is the leading medical supplies company in Northern Europe with
operations in Finland, Sweden, Norway, Denmark, the Baltic countries and Poland.
CapMan made its initial investment in OneMed in June 2006, when it acquired
Tamro Corporation's healthcare product business unit Tamro MedLab. The name of
the company was later changed to OneMed. The initial investment was followed by
several add-on investments and significant acquisitions in the Nordic region and
Poland, supporting the company's growth into a leading position in Northern
Europe. During CapMan's ownership OneMed's turnover has grown from EUR 148
million in 2006 to close to EUR 400 million pro-forma in 2010."CapMan's and the management's shared target has been to establish a market
leading position in Northern Europe through becoming the customers' one partner
in medical supplies. We are well advanced, and OneMed now enjoys a strong
strategic position. The cooperation with OneMed's management has been very
fruitful and we are very pleased to have found in 3i a new owner that is
dedicated to further develop OneMed in its next growth phase," says CapMan's
Senior Partner Ari Tolppanen, who has headed the investment in OneMed."OneMed has achieved tremendous growth during the four-year period demonstrating
that a company operating in a fragmented and complex market can, with the
assistance of an investment partner, make great progress. It is with confidence
and enthusiasm that we enter this new chapter of our development," comments
OneMed's CEO Andreas Göthberg."We are excited to get the opportunity to support Andreas and his team in
building the leading distributor of medical supplies and devices in Northern and
Eastern Europe by providing customers with quality products at competitive
prices and superior service levels. Our experience within healthcare and
distribution and our deep Asian network fits OneMed well," says 3i's Partner
Mattias Eklund.

The funds exiting OneMed are CapMan Buyout VIII, CapMan Mezzanine IV and
Finnmezzanine III B. CapMan was advised by Danske Bank Corporate Finance and DC
Advisory Partners in this transaction.

Further information:
Ari Tolppanen, Senior Partner, CapMan Buyout, tel. +358 500 407 343
Mattias Eklund, Partner, 3i, tel. +46 8 506 101 52
Andreas Göthberg, CEO, OneMed Group Oy, tel. +46 7 302 043 00


CAPMAN PLC

Mari Reponen
Communications Director
Investor Services



DISTRIBUTION
NASDAQ OMX Helsinki
Principal media
www.capman.com


CapMan
CapMan is one of the leading alternative asset managers in the Nordic countries
and Russia and manages private equity funds with approximately EUR 3.6 billion
in total capital. CapMan has six investment areas (CapMan Buyout, CapMan
Technology, CapMan Life Science, CapMan Russia, CapMan Public Market and CapMan
Real Estate), and each of them has a dedicated team and funds. Altogether CapMan
employs approximately 150 people in Helsinki, Stockholm, Copenhagen, Oslo,
Moscow and Luxembourg. CapMan was established in 1989 and its B shares have been
listed on the Helsinki Stock Exchange since 2001. www.capman.com

3i
3i is an international investor focused on Private Equity, Infrastructure and
Debt Management, investing in Europe, Asia and North America. The competitive
advantage comes from the international network and the strength and breadth of
their business relationships. These underpin the value that is delivered to
their portfolio, shareholders and fund investors.www.3i.com

OneMed Group
OneMed is the leading medical supplies wholesaler in Northern Europe serving
both public and private customers with reliable, high-quality products in
medical supplies, other supplies & related products and medical equipment. The
Company is present in Sweden, Finland, Poland, Denmark, Norway and the Baltic
countries and had pro forma turnover of EUR 346 million and approximately 700
employees in 2009. OneMed's strategic intent is to be the One Partner in Medical
Supplies.



[HUG#1471149]